Shake-up at Novartis Japan as second scandal emerges

Save

The Swiss-based firm said that several senior Japanese executives had "resigned," including the head of Novartis Japan's pharma business Yoshiyasu Ninomiya, who is succeeded by Dirk Kosche, formerly head of emerging markets at Novartis Oncology.